Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Anna Manonelles"'
Autor:
Beatriz Fernández-Alarcón, Oscar Nolberger, Anna Vidal-Alabró, Raul Rigo-Bonnin, Josep M. Grinyó, Edoardo Melilli, Nuria Montero, Anna Manonelles, Ana Coloma, Alex Favà, Sergi Codina, Josep M. Cruzado, Helena Colom, Nuria Lloberas
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
AimsThe once-daily extended-release tacrolimus formulation (ER-Tac) has demonstrated similar efficacy and safety to the twice-daily immediate-release formulation (IR-Tac), but few population-based pharmacokinetic models have been developed in de novo
Externí odkaz:
https://doaj.org/article/e1e7a764787d4907916c5088a819c282
Autor:
Anna Vidal-Alabró, Helena Colom, Pere Fontova, Gema Cerezo, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Alex Favà, Josep M. Cruzado, Joan Torras, Josep M. Grinyó, Nuria Lloberas
Publikováno v:
Nefrología (English Edition), Vol 44, Iss 2, Pp 204-216 (2024)
Background and justification: The strategy of the concentration-dose (C/D) approach and the different profiles of tacrolimus (Tac) according to the cytochrome P450 polymorphisms (CYPs) focus on the metabolism of Tac and are proposed as tools for the
Externí odkaz:
https://doaj.org/article/080bb41af9964a478495db2667e29f1c
Autor:
Néstor Toapanta, Jordi Comas, Ignacio Revuelta, Anna Manonelles, Carme Facundo, María José Pérez-Saez, Anna Vila, Emma Arcos, Jaume Tort, Magali Giral, Maarten Naesens, Dirk Kuypers, Anders Asberg, Francesc Moreso, Oriol Bestard, the EKITE consortium
Publikováno v:
Transplant International, Vol 37 (2024)
Although kidney transplantation from living donors (LD) offers better long-term results than from deceased donors (DD), elderly recipients are less likely to receive LD transplants than younger ones. We analyzed renal transplant outcomes from LD vers
Externí odkaz:
https://doaj.org/article/6e23bde4b803476492640d9abebdd733
Autor:
Edoardo Melilli, Alberto Mussetti, Gabriela Sanz Linares, Marco Ruella, Charette La Salette, Alexandre Savchenko, Maria del Rosario Taco, Nuria Montero, Josep Grinyo, Alex Fava, Montse Gomà, Maria Meneghini, Anna Manonelles, Josepmaria Cruzado, Ana Sureda, Oriol Bestard
Publikováno v:
Kidney Medicine, Vol 3, Iss 4, Pp 665-668 (2021)
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a newer and effective therapeutic option approved for patients with relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Acute kidney injury is a complication
Externí odkaz:
https://doaj.org/article/944abe382098468d84ef6dc601ac3025
Autor:
Pere Fontova, Lisanne N. van Merendonk, Anna Vidal-Alabró, Raül Rigo-Bonnin, Gema Cerezo, Stefaan van Oevelen, Oriol Bestard, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Joan Torras, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1481 (2023)
Despite intensive monitoring of whole blood tacrolimus concentrations, acute rejection after kidney transplantation occurs during tacrolimus therapy. Intracellular tacrolimus concentrations could better reflect exposure at the site of action and its
Externí odkaz:
https://doaj.org/article/17151f14f7b844a0abfe1718be0a1db2
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Chronic kidney disease (CKD) is increasing in most countries and kidney transplantation is the best option for those patients requiring renal replacement therapy. Therefore, there is a significant number of patients living with a functioning kidney a
Externí odkaz:
https://doaj.org/article/cfacc426d0eb47c7ae2bbf8776d12628
Autor:
Maria Meneghini, Elena Crespo, Matthias Niemann, Alba Torija, Nuria Lloberas, Vincent Pernin, Pere Fontova, Edoardo Melilli, Alexandre Favà, Nuria Montero, Anna Manonelles, Josep Maria Cruzado, Eduard Palou, Jaume Martorell, Josep Maria Grinyó, Oriol Bestard
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Donor/recipient molecular human leukocyte antigen (HLA) mismatch predicts primary B-cell alloimmune activation, yet the impact on de novo donor-specific T-cell alloimmunity (dnDST) remains undetermined. The hypothesis of our study is that donor/recip
Externí odkaz:
https://doaj.org/article/ebaf9f1dcca14f848c8180699c05f2a0
Autor:
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, Lisanne N. van Merendonk, Anna Vidal-Alabró, Nuria Montero, Edoardo Melilli, Maria Meneghini, Anna Manonelles, Josep M. Cruzado, Juan Torras, Josep Maria Grinyó, Oriol Bestard, Nuria Lloberas
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Tacrolimus is the backbone immunosuppressant after solid organ transplantation. Tacrolimus has a narrow therapeutic window with large intra- and inter-patient pharmacokinetic variability leading to frequent over- and under-immunosuppres
Externí odkaz:
https://doaj.org/article/919fc8842deb4744a8f2acf7f43d07ac
Autor:
Sandra Rayego-Mateos, Laura Marquez-Expósito, Raquel Rodrigues-Diez, Ana B. Sanz, Roser Guiteras, Nuria Doladé, Irene Rubio-Soto, Anna Manonelles, Sergi Codina, Alberto Ortiz, Josep M. Cruzado, Marta Ruiz-Ortega, Anna Sola
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 3, p 1542 (2022)
Chronic kidney disease (CKD) will become the fifth global cause of death by 2040, thus emphasizing the need to better understand the molecular mechanisms of damage and regeneration in the kidney. CKD predisposes to acute kidney injury (AKI) which, in
Externí odkaz:
https://doaj.org/article/8e57eae41b5b434d8de3670f69ab32f9
Autor:
Audrey Uffing, Maria José Pérez-Sáez, Gaetano La Manna, Giorgia Comai, Clara Fischman, Samira Farouk, Roberto Ceratti Manfro, Andrea Carla Bauer, Bruno Lichtenfels, Juliana B. Mansur, Hélio Tedesco-Silva, Gianna M. Kirsztajn, Anna Manonelles, Oriol Bestard, Miguel Carlos Riella, Silvia Regina Hokazono, Carlos Arias-Cabrales, Elias David-Neto, Carlucci Gualberto Ventura, Enver Akalin, Omar Mohammed, Eliyahu V. Khankin, Kassem Safa, Paolo Malvezzi, Michelle Marie O’Shaughnessy, Xingxing S. Cheng, Paolo Cravedi, Leonardo V. Riella
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Long-term outcomes in kidney transplantation (KT) have not significantly improved during the past twenty years. Despite being a leading cause of graft failure, glomerular disease (GD) recurrence remains poorly understood, due to h
Externí odkaz:
https://doaj.org/article/8d89c5831e2349b8b1857ae208bdab1b